Filshie / Guillebaud MA / Guillebaud Contraception

Science and Practice
1. Auflage 2013
ISBN: 978-1-4831-6366-6
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 332 Seiten, Web PDF

Contraception: Science and Practice serves as a guidebook for elucidating the science of contraception, and at the same time for utilizing the methods better to meet human needs. Organized into 17 chapters, this book first explores the world view on birth control, as well as the complications of combined oral contraception. Subsequent chapters show the relationship between oral contraception and cancer; practical prescribing of the combined oral contraceptive pill; the progestogen-only pill; and the systemic hormonal contraception by non-oral routes. Other chapters elucidate postcoital contraception; intrauterine contraceptive devices; male and female barrier contraceptive methods; natural family planning; and contraception for the older woman. Cervical ripening prior to termination of pregnancy; abortion; female sterilization and its reversal; vasectomy and its reversal; and progress towards a systemic male contraceptive are also discussed. This book will be valuable to physicians engaged in teaching or research in birth-control techniques, as well as a reference book and resource for many others.

Autoren/Hrsg.

Filshie, Marcus

Guillebaud MA, FRCSEd

Guillebaud, John

Inhaltsverzeichnis

1;Front Cover;1
2;Contraception: Science and Practice;4
3;Copyright Page;5
4;Table of Contents;10
5;Preface;6
6;Contributors;8
7;Chapter 1. Birth control: a world view;12
7.1;Need;12
7.2;Response;15
7.3;The private sector;18
7.4;The government sector;19
7.5;Investment and policy;20
7.6;Conclusion;21
8;Chapter 2. Metabolic effects of combined oral contraceptives;22
8.1;Historical overview;22
8.2;Pharmacology;23
8.3;Pharmacokinetics and metabolism of hormonal contraceptives;27
8.4;Oestrogen and progestogen activity;28
8.5;Venous thromboembolism;29
8.6;Carbohydrate metabolism;31
8.7;Lipid metabolism;32
8.8;Oral contraception and sex-hormone-binding globulin (SHBG);37
8.9;Gallstones and combined oral contraceptives;39
8.10;Oral contraceptives, vitamins, and minerals;39
8.11;Oral contraception and minerals;41
8.12;Drug interactions with oral contraceptive steroids;42
8.13;Other drugs;43
8.14;Conclusion;43
8.15;References;43
9;Chapter 3. Complications of combined oral contraception;50
9.1;Epidemiological methods;50
9.2;Cardiovascular system;51
9.3;Reproductive system;55
9.4;Urinary system;57
9.5;Gastrointestinal disturbances;57
9.6;Central nervous system;58
9.7;Musculoskeletal system;59
9.8;Endocrine system;59
9.9;Respiratory system;59
9.10;Immune system;60
9.11;Summary;60
9.12;References;60
10;Chapter 4. Oral contraception and cancer;63
10.1;Latent period;63
10.2;Changes in preparation;63
10.3;Breast cancer;64
10.4;Ovarian cancer;70
10.5;Endometrial cancer;71
10.6;Choriocarcinoma;72
10.7;Cancer of the cervix uteri;73
10.8;Other tumours;74
10.9;Comment;75
10.10;References;76
11;Chapter 5. Practical prescribing of the combined oral contraceptive pill;80
11.1;The pill of first choice;83
11.2;Starting routines for the combined pill;86
11.3;The paramount importance of the pill-free interval;87
11.4;Follow-up arrangements and monitoring;93
11.5;Outcome of pregnancy following or associated with COC use;97
11.6;Management of so-called minor side-effects [45];98
11.7;Summary;100
11.8;Pill myths;101
11.9;References;102
12;Chapter 6. The progestogen-only pill;105
12.1;Efficacy;106
12.2;Clinical side-effects;108
12.3;POP in lactating women;109
12.4;Metabolic effects;111
12.5;Mechanism of action;113
12.6;Starting, changing, and stopping the POP;115
12.7;Summary;115
12.8;References;116
13;Chapter 7. Systemic hormonal contraception by non-oral routes;120
13.1;Background: a continuing story of controversy;120
13.2;Practical routes of administration;122
13.3;Pharmacology;125
13.4;Clinical aspects;127
13.5;Acceptability;131
13.6;Future advances;133
13.7;References;133
14;Chapter 8. Postcoital contraception;137
14.1;The 'morning-after' pill;138
14.2;Mechanism of action of hormones used postcoitally;144
14.3;Postcoital IUD insertion;146
14.4;Future developments in postcoital contraception;147
14.5;ORF 13811;149
14.6;Conclusions;150
14.7;Appendix;150
14.8;References;151
15;Chapter 9. Intrauterine contraceptive devices;155
15.1;Mechanism of action;157
15.2;Beneficial effects;158
15.3;Effectiveness;159
15.4;Adverse effects;160
15.5;Dalkon shield;166
15.6;Clinical management;171
15.7;Classification of intrauterine contraceptive devices;174
15.8;Acceptability;176
15.9;Future advances in intrauterine contraception;177
15.10;Summary and conclusions;177
15.11;References;178
16;Chapter 10. Male and female barrier contraceptive methods;183
16.1;Condoms;183
16.2;Mechanism of action and method of use;184
16.3;Effectiveness;184
16.4;Acceptability and use;185
16.5;Advantages and disadvantages;187
16.6;Manufacture and quality control;189
16.7;Future advances;190
16.8;Diaphragms and caps;190
16.9;History;190
16.10;Mechanism of action;192
16.11;Contraindications for using a diaphragm;193
16.12;Clinical practice and procedures;193
16.13;Effectiveness;197
16.14;Acceptability and use;198
16.15;Advantages and disadvantages;198
16.16;Future advances;199
16.17;Spermicides;204
16.18;Mode of action;204
16.19;Types available and method of use;204
16.20;Effectiveness;205
16.21;Acceptability and use;206
16.22;Advantages and disadvantages;207
16.23;Future advances;209
16.24;References;210
17;Chapter 11. Natural family planning;214
17.1;Historical background;214
17.2;Fertility awareness;215
17.3;Cyclical changes in the cervix;219
17.4;The methodologies;222
17.5;The effectiveness of NFP;225
17.6;Efficient teaching;225
17.7;Advantages and disadvantages;228
17.8;Disadvantages;228
17.9;Breast-feeding and infertility;229
17.10;Research and the development of new techniques in NFP;229
17.11;Conclusion;232
17.12;References;232
18;Chapter 12. Contraception for the older woman;235
18.1;Risks to mother and fetus;235
18.2;Coital frequency and age;235
18.3;Fecundity in older women;237
18.4;Hormonal contraception;239
18.5;Non-hormonal reversible contraception;243
18.6;Irreversible methods;246
18.7;References;247
19;Chapter 13. Cervical ripening prior to termination of pregnancy;250
19.1;Prostaglandins;250
19.2;Laminaria digitata;253
19.3;Lamicel;254
19.4;Dilapan;255
19.5;Mechanisms involved in dilatation with hygroscopic dilators;256
19.6;Conclusions;258
19.7;References;258
20;Chapter 14. Abortion;261
20.1;Introduction;261
20.2;History of abortion and the law;262
20.3;Section 58;262
20.4;Effect of the Abortion Act in Britain;264
20.5;Counselling;265
20.6;Techniques for termination of pregnancy;268
20.7;Complications of abortion;276
20.8;Long-term sequelae following termination of pregnancy;278
20.9;References;279
21;Chapter 15. Female sterilization and its reversal;286
21.1;Introduction;286
21.2;Conventional laparotomy;287
21.3;Minilaparotomy;290
21.4;Colpotomy;290
21.5;Hysteroscopy;295
21.6;Reversal of sterilization;298
21.7;Conclusion;300
21.8;References;301
22;Chapter 16. Vasectomy and vasectomy reversal;303
22.1;Introduction;303
22.2;Vasectomy;304
22.3;Summary and conclusions;312
22.4;References;313
23;Chapter 17. Progress towards a systemic male contraceptive;316
23.1;Introduction;316
23.2;Interference with sperm production;316
23.3;Interference with sperm function;318
23.4;Conclusions;319
23.5;References;320
24;Index;322